Your browser doesn't support javascript.
loading
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease.
Katagishi, Daiki; Yasuda, Daisuke; Takahashi, Kyoko; Nakamura, Shigeo; Mashino, Tadahiko; Ohe, Tomoyuki.
Afiliação
  • Katagishi D; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan.
  • Yasuda D; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan.
  • Takahashi K; Department of Chemistry, Nippon Medical School, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo, Japan.
  • Nakamura S; Department of Chemistry, Nippon Medical School, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo, Japan.
  • Mashino T; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan.
  • Ohe T; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, Japan. Electronic address: ohe-tm@pha.keio.ac.jp.
Bioorg Med Chem Lett ; 80: 129121, 2023 01 15.
Article em En | MEDLINE | ID: mdl-36587873
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fulerenos / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fulerenos / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article